Search

Filters

Clear Filters
8:30 AM - 8:40 AM ET

157 - Postoperative Hypofractionated Radiotherapy for Thymic Epithelial Tumors: Efficacy and Safety Results from a Prospective, Single-Center, Phase II Trial
Speaker: Zhang, Zhihui, MD, PhD - National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy, Beijing, Beijing
8:40 AM - 8:50 AM ET

158 - Combining SBRT with GM-CSF and Peg-IFNa to Induce Abscopal Effects In Previously Treated Patients with Metastatic Thymic Tumors: A Single Institution, Phase II Trial
Speaker: Fan, Min, MD, PhD - Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai
8:00 AM - 8:10 AM ET

159 - Predicting Dysphagia and Identifying Anatomical Regions Responsible for Dysphagia Following Intensity-Modulated Radiation Therapy (IMRT) for Oropharyngeal Carcinoma
Speaker: Das, Shiva, PhD - University of North Carolina, Chapel Hill, NC
8:10 AM - 8:20 AM ET

160 - Subregional Parotid Dosiomics and DVH Integration Improves Prediction of Xerostomia after Radiotherapy for Nasopharyngeal Carcinoma
Speaker: Sun, Hongfei, PhD - Xijing Hospital, Xian 710032, Shaanxi
8:20 AM - 8:30 AM ET

161 - Evaluating CT-based Radiomics and Dosiomics Outcome Models for Locoregionally Advanced Head and Neck Cancer: A Retrospective Analysis of the NRG/RTOG 0522 trial
Speaker: Tie, Xin, PhD - University of Pennsylvania, Philadelphia, PA
8:30 AM - 8:40 AM ET

162 - Pilot Clinical Implementation and Evaluation of an AI-Based Decision Support Tool for CBCT-Guided Radiotherapy Image Review
Speaker: Luximon, Dishane, PhD - University of California Los Angeles, Los Angeles, CA
8:40 AM - 8:50 AM ET

163 - Cross-Institutional Validation of LLM-Based Cardiac Event Extraction from Electronic Health Records
Speaker: Cao, Wenchao, PhD - Thomas Jefferson University, Philadelphia, PA
8:50 AM - 9:00 AM ET

164 - Feature Interaction-Informed Deep Radiomics Unveils Tumor Heterogeneity and Predicts Distant Metastasis-Free Survival in Head and Neck Cancer: A Multicenter Study
Speaker: Xing, Lei, PhD, FASTRO - Stanford University, Stanford University, CA
10:45 AM - 10:55 AM ET

165 - Short-Course Radiotherapy-Based Total Neoadjuvant Therapy with or without a PD-1 Inhibitor in pMMR Locally Advanced Rectal Cancer: Short-Term Results from a Randomized Phase 3 Trial (STELLAR II)
Speaker: Tang, Yuan, MD - Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, Beijing
10:55 AM - 11:05 AM ET

166 - FAPI-Guided Radiotherapy + Cadonilimab with Systemic Therapy vs. Systemic Therapy Alone in Second-Line Treatment of Colorectal Peritoneal Metastasis (TORCH-PM01)
Speaker: Zhang, Zhiyuan, MD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai
11:05 AM - 11:15 AM ET

167 - Comparison of Treatment Outcome Between Short-Course Total Neoadjuvant Therapy vs. Neoadjuvant Long-Course Chemoradiotherapy Alone in Locally Advanced Rectal Adenocarcinoma: A Phase III Randomized Controlled Trial
Speaker: Barik, Sandip Kumar, MD, MBBS - King George's Medical University, Lucknow, Uttar Prad
11:15 AM - 11:25 AM ET

168 - Immunotherapy Based Total Neoadjuvant Therapy with or without Short-Course Radiotherapy for Locally Advanced Rectal Cancer: Initial Results of TORCH-iTNT
Speaker: Xia, Fan, MD, PhD - Fudan University Shanghai Cancer Center, Shanghai, Shanghai